PT1363656E - Tripeptideos e derivados de tripeptideos para o tratamento de doencas pos-lesionais do sistema nervoso - Google Patents

Tripeptideos e derivados de tripeptideos para o tratamento de doencas pos-lesionais do sistema nervoso

Info

Publication number
PT1363656E
PT1363656E PT02719767T PT02719767T PT1363656E PT 1363656 E PT1363656 E PT 1363656E PT 02719767 T PT02719767 T PT 02719767T PT 02719767 T PT02719767 T PT 02719767T PT 1363656 E PT1363656 E PT 1363656E
Authority
PT
Portugal
Prior art keywords
sub
alkyl
alkoxy
tripeptideos
treatment
Prior art date
Application number
PT02719767T
Other languages
English (en)
Inventor
Jean Rapin
Witzmann Hans Klaus
Grumel Jean-Marie
Gonella Jacques
Original Assignee
Neurotell Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurotell Ag filed Critical Neurotell Ag
Publication of PT1363656E publication Critical patent/PT1363656E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
PT02719767T 2001-02-05 2002-02-05 Tripeptideos e derivados de tripeptideos para o tratamento de doencas pos-lesionais do sistema nervoso PT1363656E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10105038A DE10105038B4 (de) 2001-02-05 2001-02-05 Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems

Publications (1)

Publication Number Publication Date
PT1363656E true PT1363656E (pt) 2005-03-31

Family

ID=7672831

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02719767T PT1363656E (pt) 2001-02-05 2002-02-05 Tripeptideos e derivados de tripeptideos para o tratamento de doencas pos-lesionais do sistema nervoso

Country Status (8)

Country Link
US (1) US7122524B2 (pt)
EP (1) EP1363656B1 (pt)
JP (1) JP4183507B2 (pt)
AT (1) ATE285244T1 (pt)
DE (2) DE10105038B4 (pt)
ES (1) ES2230480T3 (pt)
PT (1) PT1363656E (pt)
WO (1) WO2002062373A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10105038B4 (de) 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105041A1 (de) 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
DE10105040A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
JP2011201923A (ja) * 2005-07-01 2011-10-13 Snow Brand Milk Products Co Ltd ジペプチジルペプチダーゼｉｖ阻害剤
CN106317177A (zh) * 2015-06-23 2017-01-11 首都医科大学 Gly-Phe-Pro,其合成,活性和应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1323301C (en) * 1987-06-05 1993-10-19 Alan I. Faden Thyrotropin-releasing hormone analogs in cns injury
FR2622581B1 (fr) 1987-11-03 1990-02-16 Inorgan Sa Rech Develop Pharm Nouveaux derives de l-proline, leur preparation et leurs applications biologiques
EP0445606B1 (en) * 1990-02-27 1997-01-22 The Agency of Industrial Science and Technology Novel oligopeptides, pharmaceutical composition and food containing the same, and use of oligopeptides
DE4007869A1 (de) 1990-03-13 1991-09-19 Merck Patent Gmbh Aminosaeurederivate
JPH045240A (ja) 1990-04-20 1992-01-09 Taisho Pharmaceut Co Ltd 抗痴呆剤
US5091391A (en) * 1990-08-16 1992-02-25 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of resisting neurodegenerative disorders
EP0564552A1 (en) 1990-12-28 1993-10-13 Cortex Pharmaceuticals, Inc. Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
WO1992013549A1 (en) * 1991-02-07 1992-08-20 Research Corporation Technologies, Inc. Inhibition of cell proliferation by hydrophobic peptides
US6235929B1 (en) 1991-12-27 2001-05-22 Georgia Tech Research Corporation Tripeptide α-ketoamides
US7067326B2 (en) * 1994-01-13 2006-06-27 The Trustees Of Columbia University In The City Of New York Synthetic receptors, libraries and uses thereof
US5716929A (en) 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US5834029A (en) 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
JPH0940577A (ja) * 1995-05-24 1997-02-10 Mitsui Toatsu Chem Inc トリペプチド、ジペプチドを含有する医薬組成物
EP0840614A1 (en) 1995-06-13 1998-05-13 Sanofi Winthrop, Inc. Calpain inhibitors for the treatment of neurodegenerative diseases
JPH09169797A (ja) * 1995-12-22 1997-06-30 Mitsui Toatsu Chem Inc プロテアーゼアクティベーター活性を有するペプチド
US5840838A (en) * 1996-02-29 1998-11-24 University Of Kentucky Research Foundation Process for enhancing the activity of amyloid β peptides
JP2001501930A (ja) * 1996-10-04 2001-02-13 オークランド ユニサーヴィスィズ リミテッド 神経酵素の調節
JP4727770B2 (ja) 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
US6080848A (en) * 1998-05-01 2000-06-27 Incyte Pharmaceuticals, Inc. Human brain associated protein
US6379691B1 (en) * 1998-09-29 2002-04-30 Medtronic/Ave, Inc. Uses for medical devices having a lubricious, nitric oxide-releasing coating
WO2001028578A2 (en) * 1999-10-22 2001-04-26 Wrair A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME
JP4633876B2 (ja) 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
AU2001247334A1 (en) 2000-03-10 2001-09-24 Monsanto Company Novel peptides with anti-hypertensive activity
DE10105038B4 (de) 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105041A1 (de) 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
US6846641B2 (en) * 2002-04-23 2005-01-25 Agy Therapeutics, Inc. In vitro ischemia model

Also Published As

Publication number Publication date
EP1363656B1 (en) 2004-12-22
DE10105038A1 (de) 2002-08-14
DE60202356T2 (de) 2005-12-08
DE10105038B4 (de) 2005-07-07
JP4183507B2 (ja) 2008-11-19
EP1363656A2 (en) 2003-11-26
WO2002062373A2 (en) 2002-08-15
WO2002062373A3 (en) 2002-11-14
JP2004526702A (ja) 2004-09-02
ATE285244T1 (de) 2005-01-15
US20050080016A1 (en) 2005-04-14
DE60202356D1 (de) 2005-01-27
US7122524B2 (en) 2006-10-17
ES2230480T3 (es) 2005-05-01

Similar Documents

Publication Publication Date Title
CY1107990T1 (el) Τριπεπτιδια και παραγωγα τριπεπτιδιων για τη θepαπεια νευροεκφυλιστικων ασθενειων
HUP0000492A1 (hu) N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával
IL145430A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
TR200100438T2 (tr) Hepatit C inhibitörü peptitler
MY134190A (en) Compositions and methods for stimulating gastrointestinal motility.
ES2187958T3 (es) Antagonistas de gnrh.
ATE355297T1 (de) Tgf-beta inhibitoren und methoden
YU33700A (sh) Kombinacija efikasna u tretiranju impotencije
BR0209452A (pt) Composto de cefem, processo para sua preparação, composição farmacêutica e uso do composto
PT1363656E (pt) Tripeptideos e derivados de tripeptideos para o tratamento de doencas pos-lesionais do sistema nervoso
FI956055A (fi) Tekijä VII:sta johdettuja peptidejä
HUP0202729A2 (hu) Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények
MXPA02004505A (es) Peptidos mimeticos para epitope de apolipoproteinab-100 concatamero y peptidos modificados del mismo, y la composicion de vacuna que comprende los mismos.
UY26911A1 (es) Ácidos amino (oxo) acéticos inhibidores de la proteina tirosina fosfatasa
RS50423B (sr) Novi derivati oktahidro-6,10-diokso-6h-piridazino(1,2-a) (1,2) diazepin-1-karboksilne kiseline, njihov postupak dobijanja i njihova primena za dobijanje farmaceutski aktivnih jedinjenja
ATE310529T1 (de) Tripeptidderivate zur behandlung von postläsionalen krankheiten des nervensystems
EA200400603A1 (ru) Новые пептиды - аналоги гормона высвобождения гормона роста человека
KR890009974A (ko) 신규 화합물들
DK1794182T3 (en) RELATIONS modulates TRH-EFFECTS AND INHIBITS TRH DECOMPOSITION ENZYME
NZ519062A (en) Peptides for treatment of erectile dysfunction
WO2002083729A3 (en) Polypeptides derived from amyloid precursor peptide (app) and their uses
ATE360432T1 (de) Peptid zur behandlung von nervenerkrankungen
HUP0300083A2 (hu) Készítmény immunszupresszív szerek alkalmazása által indukált citotoxikus hatások kezelésére és/vagy megelőzésére
EP1452522A3 (en) Novel compounds and compositions as protease inhibitors
TH79013A (th) อะนาลอกบอมเบซินสำหรับการรักษามะเร็ง